Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

A Machine Learning Approach to Identify NIH-Funded Applied Prevention Research.

Villani J, Schully SD, Meyer P, Myles RL, Lee JA, Murray DM, Vargas AJ.

Am J Prev Med. 2018 Dec;55(6):926-931. doi: 10.1016/j.amepre.2018.07.024. Epub 2018 Oct 25.

PMID:
30458951
2.

NIH Primary and Secondary Prevention Research in Humans During 2012-2017.

Murray DM, Villani J, Vargas AJ, Lee JA, Myles RL, Wu JY, Mabry PL, Schully SD.

Am J Prev Med. 2018 Dec;55(6):915-925. doi: 10.1016/j.amepre.2018.08.006. Epub 2018 Oct 25.

PMID:
30458950
3.

Training the Twenty-First Century Cancer Epidemiologist.

Lam TK, Lavigne JA, Qadir X, Khoury MJ, Schully SD.

J Cancer Educ. 2018 Sep 24. doi: 10.1007/s13187-018-1426-5. [Epub ahead of print]

PMID:
30251077
4.

Correction: A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.

Khoury MJ, Feero WG, Chambers DA, Brody LC, Aziz N, Green RC, Janssens ACJW, Murray MF, Rodriguez LL, Rutter JL, Schully SD, Winn DM, Mensah GA.

PLoS Med. 2018 Aug 16;15(8):e1002650. doi: 10.1371/journal.pmed.1002650. eCollection 2018 Aug.

5.

A collaborative translational research framework for evaluating and implementing the appropriate use of human genome sequencing to improve health.

Khoury MJ, Feero WG, Chambers DA, Brody LC, Aziz N, Green RC, Janssens ACJW, Murray MF, Rodriguez LL, Rutter JL, Schully SD, Winn DM, Mensah GA.

PLoS Med. 2018 Aug 2;15(8):e1002631. doi: 10.1371/journal.pmed.1002631. eCollection 2018 Aug. Erratum in: PLoS Med. 2018 Aug 16;15(8):e1002650.

6.

Trends in published meta-analyses in cancer research, 2008-2013.

Qadir XV, Clyne M, Lam TK, Khoury MJ, Schully SD.

Cancer Causes Control. 2017 Jan;28(1):5-12. doi: 10.1007/s10552-016-0830-6. Epub 2016 Nov 29.

7.

A standardized, evidence-based protocol to assess clinical actionability of genetic disorders associated with genomic variation.

Hunter JE, Irving SA, Biesecker LG, Buchanan A, Jensen B, Lee K, Martin CL, Milko L, Muessig K, Niehaus AD, O'Daniel J, Piper MA, Ramos EM, Schully SD, Scott AF, Slavotinek A, Sobreira N, Strande N, Weaver M, Webber EM, Williams MS, Berg JS, Evans JP, Goddard KA.

Genet Med. 2016 Dec;18(12):1258-1268. doi: 10.1038/gim.2016.40. Epub 2016 Apr 28.

8.

Review of the Gene-Environment Interaction Literature in Cancer: What Do We Know?

Simonds NI, Ghazarian AA, Pimentel CB, Schully SD, Ellison GL, Gillanders EM, Mechanic LE.

Genet Epidemiol. 2016 Jul;40(5):356-65. doi: 10.1002/gepi.21967. Epub 2016 Apr 7. Review.

9.

Reproducible Research Practices and Transparency across the Biomedical Literature.

Iqbal SA, Wallach JD, Khoury MJ, Schully SD, Ioannidis JP.

PLoS Biol. 2016 Jan 4;14(1):e1002333. doi: 10.1371/journal.pbio.1002333. eCollection 2016 Jan.

10.

What is translational genomics? An expanded research agenda for improving individual and population health.

Schully SD, Khoury MJ.

Appl Transl Genom. 2014 Dec;3(4):82-83. No abstract available.

11.

Robustness of Next Generation Sequencing on Older Formalin-Fixed Paraffin-Embedded Tissue.

Carrick DM, Mehaffey MG, Sachs MC, Altekruse S, Camalier C, Chuaqui R, Cozen W, Das B, Hernandez BY, Lih CJ, Lynch CF, Makhlouf H, McGregor P, McShane LM, Phillips Rohan J, Walsh WD, Williams PM, Gillanders EM, Mechanic LE, Schully SD.

PLoS One. 2015 Jul 29;10(7):e0127353. doi: 10.1371/journal.pone.0127353. eCollection 2015.

12.

Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):451-8. doi: 10.1093/aje/kwu479. Epub 2015 Mar 11. Review.

13.

Lam et al. respond to "Driving for further evolution".

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD.

Am J Epidemiol. 2015 Apr 1;181(7):463. doi: 10.1093/aje/kwu478. Epub 2015 Mar 11. No abstract available.

PMID:
25767264
14.

The authors reply.

Spitz MR, Lam TK, Schully SD, Khoury MJ.

Am J Epidemiol. 2015 Mar 1;181(5):361. doi: 10.1093/aje/kwv019. Epub 2015 Feb 18. No abstract available.

15.

Leveraging biospecimen resources for discovery or validation of markers for early cancer detection.

Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, Berg CD, Cullen J, Diamandis EP, Doria-Rose VP, Goddard KA, Hankinson SE, Kushi LH, Larson EB, McShane LM, Schilsky RL, Shak S, Skates SJ, Urban N, Kramer BS, Khoury MJ, Ransohoff DF.

J Natl Cancer Inst. 2015 Feb 16;107(4). pii: djv012. doi: 10.1093/jnci/djv012. Print 2015 Apr.

16.

SEER cancer registry biospecimen research: yesterday and tomorrow.

Altekruse SF, Rosenfeld GE, Carrick DM, Pressman EJ, Schully SD, Mechanic LE, Cronin KA, Hernandez BY, Lynch CF, Cozen W, Khoury MJ, Penberthy LT.

Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2681-7. doi: 10.1158/1055-9965.EPI-14-0490. Review.

17.

Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.

Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully SD.

Public Health Genomics. 2015;18(2):67-77. doi: 10.1159/000368745.

18.

The Cancer Genomics and Epidemiology Navigator: An NCI online tool to enhance cancer epidemiology research.

Schully SD, Rogers SD, Lam TK, Chang CQ, Clyne M, Cyr J, Watson D, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2610-1. doi: 10.1158/1055-9965.EPI-14-0902. No abstract available.

19.

An overview of recommendations and translational milestones for genomic tests in cancer.

Chang CQ, Tingle SR, Filipski KK, Khoury MJ, Lam TK, Schully SD, Ioannidis JP.

Genet Med. 2015 Jun;17(6):431-40. doi: 10.1038/gim.2014.133. Epub 2014 Oct 23. Review.

20.

The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists.

Spitz MR, Lam TK, Schully SD, Khoury MJ.

Am J Epidemiol. 2014 Nov 15;180(10):964-7. doi: 10.1093/aje/kwu256. Epub 2014 Sep 18. Review.

21.

The use of biospecimens in population-based research: a review of the National Cancer Institute's Division of Cancer Control and Population Sciences grant portfolio.

Carrick DM, Mette E, Hoyle B, Rogers SD, Gillanders EM, Schully SD, Mechanic LE.

Biopreserv Biobank. 2014 Aug;12(4):240-5. doi: 10.1089/bio.2014.0009. Review.

22.

Evidence synthesis and guideline development in genomic medicine: current status and future prospects.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ.

Genet Med. 2015 Jan;17(1):63-7. doi: 10.1038/gim.2014.69. Epub 2014 Jun 19.

23.

Multi-marker Solid Tumor Panels Using Next-generation Sequencing to Direct Molecularly Targeted Therapies.

Marrone M, Filipski KK, Gillanders EM, Schully SD, Freedman AN.

PLoS Curr. 2014 May 27;6. pii: ecurrents.eogt.aa5415d435fc886145bd7137a280a971. doi: 10.1371/currents.eogt.aa5415d435fc886145bd7137a280a971.

24.

Collaborative biomedicine in the age of big data: the case of cancer.

Shaikh AR, Butte AJ, Schully SD, Dalton WS, Khoury MJ, Hesse BW.

J Med Internet Res. 2014 Apr 7;16(4):e101. doi: 10.2196/jmir.2496.

25.

Horizon scanning for translational genomic research beyond bench to bedside.

Clyne M, Schully SD, Dotson WD, Douglas MP, Gwinn M, Kolor K, Wulf A, Bowen MS, Khoury MJ.

Genet Med. 2014 Jul;16(7):535-8. doi: 10.1038/gim.2013.184. Epub 2014 Jan 9.

26.

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method.

Dotson WD, Douglas MP, Kolor K, Stewart AC, Bowen MS, Gwinn M, Wulf A, Anders HM, Chang CQ, Clyne M, Lam TK, Schully SD, Marrone M, Feero WG, Khoury MJ.

Clin Pharmacol Ther. 2014 Apr;95(4):394-402. doi: 10.1038/clpt.2013.226. Epub 2014 Feb 19. Review.

27.

Translation of genetics research to clinical medicine: the National Heart, Lung, and Blood Institute perspective.

Puggal MA, Schully SD, Srinivas PR, Papanicolaou GJ, Jaquish CE, Fabsitz RR.

Circ Cardiovasc Genet. 2013 Dec;6(6):634-9. doi: 10.1161/CIRCGENETICS.113.000227. No abstract available. Erratum in: Circ Cardiovasc Genet. 2014 Aug;7(4):569.

28.

Epigenetic research in cancer epidemiology: trends, opportunities, and challenges.

Verma M, Rogers S, Divi RL, Schully SD, Nelson S, Joseph Su L, Ross SA, Pilch S, Winn DM, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):223-33. doi: 10.1158/1055-9965.EPI-13-0573. Epub 2013 Dec 10. Review.

29.

Potential increased risk of cancer from commonly used medications: an umbrella review of meta-analyses.

Ioannidis JP, Zhou Y, Chang CQ, Schully SD, Khoury MJ, Freedman AN.

Ann Oncol. 2014 Jan;25(1):16-23. doi: 10.1093/annonc/mdt372. Epub 2013 Dec 4. Review.

30.

A systematic review of cancer GWAS and candidate gene meta-analyses reveals limited overlap but similar effect sizes.

Chang CQ, Yesupriya A, Rowell JL, Pimentel CB, Clyne M, Gwinn M, Khoury MJ, Wulf A, Schully SD.

Eur J Hum Genet. 2014 Mar;22(3):402-8. doi: 10.1038/ejhg.2013.161. Epub 2013 Jul 24.

31.

The geometric increase in meta-analyses from China in the genomic era.

Ioannidis JP, Chang CQ, Lam TK, Schully SD, Khoury MJ.

PLoS One. 2013 Jun 12;8(6):e65602. doi: 10.1371/journal.pone.0065602. Print 2013.

32.

How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry.

Keogh LA, Fisher D, Sheinfeld Gorin S, Schully SD, Lowery JT, Ahnen DJ, Maskiell JA, Lindor NM, Hopper JL, Burnett T, Holter S, Arnold JL, Gallinger S, Laurino M, Esplen MJ, Sinicrope PS; Colon Cancer Family Registry.

J Community Genet. 2014 Apr;5(2):99-108. doi: 10.1007/s12687-013-0148-y. Epub 2013 May 24.

33.

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.

Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN.

J Natl Cancer Inst. 2013 Jul 3;105(13):929-36. doi: 10.1093/jnci/djt108. Epub 2013 May 9.

34.

A review of NCI's extramural grant portfolio: identifying opportunities for future research in genes and environment in cancer.

Ghazarian AA, Simonds NI, Bennett K, Pimentel CB, Ellison GL, Gillanders EM, Schully SD, Mechanic LE.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):501-7. doi: 10.1158/1055-9965.EPI-13-0156. Epub 2013 Mar 5. Review.

35.

Transforming epidemiology for 21st century medicine and public health.

Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):508-16. doi: 10.1158/1055-9965.EPI-13-0146. Epub 2013 Mar 5.

36.

Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints.

Lam TK, Schully SD, Rogers SD, Benkeser R, Reid B, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):496-500. doi: 10.1158/1055-9965.EPI-13-0101. Epub 2013 Feb 14. Review.

37.

"Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities.

Lam TK, Spitz M, Schully SD, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2013 Feb;22(2):181-8. doi: 10.1158/1055-9965.EPI-12-1262. Epub 2013 Jan 15.

38.

Knowledge integration in cancer: current landscape and future prospects.

Ioannidis JP, Schully SD, Lam TK, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2013 Jan;22(1):3-10. doi: 10.1158/1055-9965.EPI-12-1144. Epub 2012 Oct 23. Review.

39.

Frontiers in cancer epidemiology: a challenge to the research community from the Epidemiology and Genomics Research Program at the National Cancer Institute.

Khoury MJ, Freedman AN, Gillanders EM, Harvey CE, Kaefer C, Reid BC, Rogers S, Schully SD, Seminara D, Verma M.

Cancer Epidemiol Biomarkers Prev. 2012 Jul;21(7):999-1001. doi: 10.1158/1055-9965.EPI-12-0525. Epub 2012 Jun 4.

40.

Multilevel research and the challenges of implementing genomic medicine.

Khoury MJ, Coates RJ, Fennell ML, Glasgow RE, Scheuner MT, Schully SD, Williams MS, Clauser SB.

J Natl Cancer Inst Monogr. 2012 May;2012(44):112-20. doi: 10.1093/jncimonographs/lgs003.

41.

Knowledge integration at the center of genomic medicine.

Khoury MJ, Gwinn M, Dotson WD, Schully SD.

Genet Med. 2012 Jul;14(7):643-7.

42.

Building the evidence base for decision making in cancer genomic medicine using comparative effectiveness research.

Goddard KA, Knaus WA, Whitlock E, Lyman GH, Feigelson HS, Schully SD, Ramsey S, Tunis S, Freedman AN, Khoury MJ, Veenstra DL.

Genet Med. 2012 Jul;14(7):633-42. Review.

43.

Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies.

Deverka PA, Schully SD, Ishibe N, Carlson JJ, Freedman A, Goddard KA, Khoury MJ, Ramsey SD.

Genet Med. 2012 Jul;14(7):656-62. Erratum in: Genet Med. 2013 Jan;15(1):91.

44.

How can we stimulate translational research in cancer genomics beyond bench to bedside?

Schully SD, Benedicto CB, Khoury MJ.

Genet Med. 2012 Jan;14(1):169-70. doi: 10.1038/gim.2011.12. No abstract available.

PMID:
22237448
45.

Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.

Bellcross CA, Bedrosian SR, Daniels E, Duquette D, Hampel H, Jasperson K, Joseph DA, Kaye C, Lubin I, Meyer LJ, Reyes M, Scheuner MT, Schully SD, Senter L, Stewart SL, St Pierre J, Westman J, Wise P, Yang VW, Khoury MJ.

Genet Med. 2012 Jan;14(1):152-62. doi: 10.1038/gim.0b013e31823375ea. Epub 2011 Oct 27.

46.

Population sciences, translational research, and the opportunities and challenges for genomics to reduce the burden of cancer in the 21st century.

Khoury MJ, Clauser SB, Freedman AN, Gillanders EM, Glasgow RE, Klein WM, Schully SD.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2105-14. doi: 10.1158/1055-9965.EPI-11-0481. Epub 2011 Jul 27. Review.

47.

Cancer GAMAdb: database of cancer genetic associations from meta-analyses and genome-wide association studies.

Schully SD, Yu W, McCallum V, Benedicto CB, Dong LM, Wulf A, Clyne M, Khoury MJ.

Eur J Hum Genet. 2011 Aug;19(8):928-30. doi: 10.1038/ejhg.2011.53. Epub 2011 Apr 13.

48.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Clin Invest. 2011 Sep;41(9):1010-35. doi: 10.1111/j.1365-2362.2011.02493.x. Epub 2011 Mar 15.

PMID:
21434890
49.

Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

Eur J Epidemiol. 2011 Apr;26(4):313-37. doi: 10.1007/s10654-011-9551-z.

50.

Strengthening the reporting of Genetic RIsk Prediction Studies (GRIPS): explanation and elaboration.

Janssens AC, Ioannidis JP, Bedrosian S, Boffetta P, Dolan SM, Dowling N, Fortier I, Freedman AN, Grimshaw JM, Gulcher J, Gwinn M, Hlatky MA, Janes H, Kraft P, Melillo S, O'Donnell CJ, Pencina MJ, Ransohoff D, Schully SD, Seminara D, Winn DM, Wright CF, van Duijn CM, Little J, Khoury MJ.

J Clin Epidemiol. 2011 Aug;64(8):e1-e22. doi: 10.1016/j.jclinepi.2011.02.003. Epub 2011 Mar 16.

PMID:
21414753

Supplemental Content

Loading ...
Support Center